Licenses, supervision, and the public records behind them. 45 articles, newest first.
Florida generally recognizes legal adulthood at 18, while FDA-approved dermal-filler uses have product-specific age boundaries. An adult's ability to consent does not make an under-22 lip-filler use FDA approved or determine whether a clinician should offer it.
Informed consent connects the actual product and procedure to alternatives, material risks, and a voluntary decision. A reusable form records that conversation; it does not replace it.
“Functional medicine doctor” is not itself a Florida health-profession license category. Lawful scope comes from the person's underlying license and setting; private functional-medicine certificates can document education but do not independently expand prescribing, testing, diagnosis, or specialist-title authority.
Obesity medicine is a clinical focus and voluntary credential layered on a professional license; “weight-loss clinic” describes a business setting. Verify the diagnosing and prescribing clinician, credentials, team roles, medication source, monitoring, referrals, records, and long-term ownership.
Hospital privileges, board certification, office registration, facility accreditation, and a Florida transfer agreement are separate records. Privileges link a clinician and specified procedures to a hospital; the other records cover specialty standards, sites, or a bounded transfer pathway.
Oculoplastic, plastic, and facial plastic surgeons reach eyelid work through different primary training pathways; no title is universally best. Match the eye or facial problem and exact procedure with verified boards, fellowship, case experience, privileges, facility, and complication plan.
Trichologist, dermatologist, and hair-transplant surgeon describe different—and sometimes overlapping—roles. The title alone does not reveal a Florida license, diagnostic authority, recognized board certification, prescribing scope, or who performs each part of surgery.
A Florida Health Care Clinic Establishment permit concerns a location's purchase of prescription drugs in the entity's name. An AHCA health care clinic license or exemption concerns a different oversight framework. Neither substitutes for individual licensure or FDA drug approval.
An anesthesiologist, certified registered nurse anesthetist, and anesthesiologist assistant hold different Florida credentials. Verify each named person, license, role, required relationship, anesthesia depth, monitoring, rescue, handoff, and recovery coverage without ranking titles in isolation.
A CE mark and FDA authorization belong to different jurisdictions. A CE-marked device may meet applicable European requirements, but that does not establish U.S. status for the same model, software, accessories, and use. Verify the EU record and the FDA classification, exemption, 510(k), De Novo, or PMA separately.
In Florida, a wellness title does not establish a nutrition credential. Verify the individual's state record, exact title, services, and who owns diagnosis, nutrition therapy, prescriptions, lab interpretation, and referrals. A coaching certificate and a Florida health-profession license answer different questions.
No. A “research use only” disclaimer does not make a peptide an FDA-approved human drug or override evidence of intended human use. Verify the molecule and product, approval record, source, claims, route, prescriber, pharmacy, label, testing, and any legitimate study or lawful compounding basis.
A 510(k) clears through substantial equivalence to a predicate; De Novo grants a new Class I or II classification for a novel low- or moderate-risk device without a suitable predicate; PMA approves a Class III device after the most stringent application review. Each is product- and intended-use-specific.
Breakthrough Device designation gives an eligible device prioritized FDA interaction during development; it is not permission to market. A designated device still needs the applicable 510(k) clearance, De Novo grant, or PMA approval for its exact intended use. Verify both records and their dates.
A Form FDA 483 lists investigator observations at inspection closeout; it is not a final agency determination. A warning letter is a separate compliance communication, while the inspection report and NAI, VAI, or OAI classification add other stages. Read every dated record and current status.
A complaint, legal-sufficiency review, investigation, probable cause, administrative complaint, emergency action, settlement, final order, and license status are different Florida records. A complaint is not a final finding; an empty result is not a lifetime clean-history guarantee.
Florida physician profiles may show malpractice-insurance or financial-responsibility information, but state law permits multiple pathways and notices. Read the exact election, profession, profile date, policy period, entity, and procedure context. The record is not a quality score or payment promise.
As of September 7, 2026, the cited Wegovy and Foundayo FDA records document approved tablets and an injection; they do not establish approval for drops, patches, sprays, troches, or films. A new route cannot borrow another product's approval. Verify the ingredient, route, source, label, evidence, and supply.
Florida hospitals and ASCs are AHCA-licensed facilities. A physician office is generally outside the ASC definition unless it is or seeks to be Medicare ASC-certified; qualifying medical-doctor office surgery follows separate DOH registration and inspection rules. None is a safety score.
Plastic surgery names a recognized specialty training and certification pathway; cosmetic surgeon is a practice description that does not identify one standardized specialty credential. Verify the Florida license, exact board, training, facility, procedure experience, team, and complication plan.
A UDI identifies a device version or model and may carry production identifiers on its label; AccessGUDID stores the device-identifier record, not a patient's lot or serial. An implant card, operative log, medical record, manufacturer registration, and FDA tracking record answer different traceability questions.
USP or NSF certification, a certificate of analysis, cGMP compliance, FDA food-facility registration, and specific notifications are different records. None proves that a supplement is FDA approved or clinically effective; verify the exact product, batch, issuer, scope, methods, dates, and health claim separately.
A ClinicalTrials.gov record is sponsor- or investigator-submitted study disclosure. It is not FDA or NIH approval, proof that an IND or IDE is in effect, IRB approval, successful enrollment, posted results, lawful marketing, or evidence that the intervention works. Verify each layer separately.
FDA-approved growth hormone products treat limited conditions; anti-aging, bodybuilding, and athletic-enhancement claims do not create authorized distribution uses. A low IGF-1, online questionnaire, compounded vial, import, or prescription does not by itself establish an approved indication or lawful product path.
CMS Open Payments reports specified payments and ownership interests from drug and device companies to covered clinicians and teaching hospitals. A record is not proof of wrongdoing, endorsement, malpractice, or quality; it is one disclosure to match by identity, year, payer, nature, amount, and context.
A cosmetic facility registration or product listing under MoCRA is an administrative record, not FDA approval, certification, safety testing, or endorsement. Verify the responsible person, facility, product identity, label, claims, adverse-event contact, and any applicable exemption separately.
An NDC identifies a listed drug product and package; it does not mean FDA verified the submitted listing or approved the product. Approved and unapproved products, repackaged products, and some reported compounded drugs can appear in the directory. Approval must be matched to an NDA, ANDA, or BLA and current labeling.
An NPI is an administrative identifier; it does not validate licensure or credentials. A state license establishes profession-specific authority in that state. DEA registration covers authorized controlled-substance activities under federal and state law. None substitutes for the others or for a facility record.
Florida does not issue a credential named “medical aesthetician.” A person using that title may hold a facial-specialist registration, cosmetology license, health-profession license, or another credential; each has its own scope. Verify the exact person, license, service, setting, and supervision.
A report in FDA's AEMS or MAUDE data means an event was submitted with a named regulated product; it does not prove causation, incidence, or comparative risk. Use reports as signals, then check product scope, denominators, verification, duplicates, follow-up, and FDA conclusions.
An FDA recall, warning letter, and safety communication are different records. A recall addresses product correction or removal; a warning letter identifies alleged significant violations and requests correction; a safety communication shares risk information and actions. Read each record's scope and updates.
For care within Florida §456.057's practitioner and setting scope, identify the records owner or custodian and request the complete existing record in writing. HIPAA may overlap only for covered entities, and other professions or facilities can follow different access rules.
A wellness label does not decide FDA status. A product may be outside the device definition, within a low-risk enforcement policy, regulated but exempt from a premarket submission, or covered by product-specific authorization. The first three are not clearance or approval.
Verify the exact legal name and address in state and FDA records, then trace the finished product, lot, prescription or office-stock path, inspection history, and recalls. A pharmacy license or 503B registration does not make a compounded drug FDA approved.
CLIA certification addresses the laboratory and its testing quality systems. FDA approval, clearance, or authorization addresses a specific test and intended use. A lab certificate does not convert an LDT into an FDA-authorized test, and an authorized kit still must be performed under the applicable laboratory rules.
A Florida-licensed professional generally does not need a separate Florida telehealth registration to treat a patient located in Florida. An eligible out-of-state professional generally must hold an active Florida telehealth registration unless a statutory exception or compact authority applies.
One event may belong in several systems. Urgent medical care comes first; FDA receives product and device reports, Florida health regulators receive professional or unlicensed-practice complaints, and consumer agencies receive deceptive-sales concerns. Preserve one factual evidence packet, then route copies.
A professional license grants legal authority within a defined scope, board certification documents additional specialty standards, and an injector certificate usually records completion of a private course. These credentials are complementary, not interchangeable.
FDA approval, clearance, authorization, establishment registration, and device listing describe different regulatory facts. For a med-spa claim to be meaningful, it must identify the exact product, the exact status, and the intended use covered by that record.
Florida treats laser and light-based hair removal as electrology when performed by a properly trained licensed electrologist. Verification includes the individual license, training for laser or light modalities, the electrology facility record, written protocols, physician supervision, and the exact device.
“Med spa” is not enough to identify a Florida regulator. The services, people, devices, and exact address determine whether to check health-profession licenses, a cosmetology salon license, an electrology facility license, or more than one record.
Florida office surgery registration, state inspection, and private accreditation are related but separate records. The procedure level and setting determine what should be verifiable before an office-based surgery.
Florida injection authority cannot be determined from the job title “injector” alone. It depends on the person's active professional license, the prescription or order, statutory scope, delegation and supervision rules, training, setting, and the exact drug or filler task.
Florida's license searches are free and take about two minutes: the Department of Health portal for doctors, nurses, PAs, and other health professions, and DBPR for estheticians and cosmetologists. Here is how to search, what each result means, and which licenses can inject Botox and filler.
The title is most useful when it leads to named clinicians, clear professional roles, and public license records. Here is what to confirm before an appointment.
